Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 19, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K

Prevention program for Clostridium difficile infection: a single-centre Serbian experience.

Snezana Brkic1, Rinaldo Pellicano, Vesna Turkulov

  • 1Medical Faculty Novi Sad, Clinical Centre of Vojvodina for Infectious Diseases, University of Novi Sad, Novi Sad, Serbia - brkicsnezana@yahoo.com.

Minerva Medica
|June 16, 2016
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical, Metabolic, and Virological Insights into Hepatitis C Virus-Infected Patients through the Combinatorial Metabolic Dysfunction-associated Steatotic Liver Disease Framework: Evidence from an Italian Cohort.

Journal of gastrointestinal and liver diseases : JGLD·2026
Same author

Guar Gum, Partially Hydrolyzed Guar Gum, and Human Gut Health: A Narrative Review.

Reviews on recent clinical trials·2026
Same author

Metabolic Dysfunction-Associated Steatotic Liver Disease and Incretin Receptor Agonists: A Metabolic Approach to Halting Liver Disease Progression.

Medicina (Kaunas, Lithuania)·2026
Same author

Gastrointestinal Health: Clinical Research and Therapeutic Innovations.

Life (Basel, Switzerland)·2026
Same author

Immunonutrition for the Management of Postsurgery GI Cancer Patients.

Nutrients·2026
Same author

Bacteriophage Therapy Against <i>Shigella</i> spp.: A Precision Antimicrobial Strategy.

Antibiotics (Basel, Switzerland)·2026

Implementing a Clostridium difficile infection (CDI) prevention program significantly reduced hospital-acquired CDI rates and associated costs. This initiative demonstrated a substantial decrease in infection incidence, highlighting the program's effectiveness in healthcare settings.

Area of Science:

  • Infectious Diseases
  • Hospital Epidemiology
  • Public Health

Background:

  • Clostridium difficile (C. difficile) infection (CDI) is a growing nosocomial concern, exacerbated by an aging population and hypervirulent strains.
  • Rising incidence of CDI necessitates effective interventional strategies to mitigate its impact.

Purpose of the Study:

  • To evaluate the impact of the Schülke preventive program on the incidence of intrahospital Clostridium difficile infection (CDI).

Main Methods:

  • An observational study compared the Schülke preventive program against standard protocols over four months.
  • A 1:4 ratio of healthcare facility-associated (HCFA) CDI patients to controls was used for comparison.
  • Statistical analysis included nonparametric tests, ANOVA, and regression analysis.

Related Experiment Videos

Last Updated: Mar 19, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K

Main Results:

  • Patients with HCFA CDI were significantly older and had longer hospital stays (14.52 days longer).
  • HCFA CDI substantially increased hospitalization costs.
  • The annual incidence of CDI decreased from 49.01 to 18.22 per 10,000 bed days after program implementation.

Conclusions:

  • The Schülke preventive program, implemented in 2014, significantly reduced hospital-acquired CDI incidence.
  • The program resulted in considerable cost savings for the hospital.